Artículos por temáticas

Exploring the role of gut microbiota in Parkinson's disease: insights from fecal microbiota transplantation

Guo M, Gao H, Wang Y, Xiang Y.

Front Neurosci. 2025 Jun 13;19:1574512. doi: 10.3389/fnins.2025.1574512. eCollection 2025.

Overcoming the dopamine-centric model of impulse control disorders in Parkinson's disease: the role of 5-HT

Cilia R, Kaasinen V.

Brain. 2025 Jun 3;148(6):1853-1856. doi: 10.1093/brain/awaf145.

Nanosensors for hazardous pesticides and nanofertilizers for sustainable agriculture: contribution of carbon quantum dots

Biswas T, Raut J, De D, Sahoo P.

Dalton Trans. 2025 Jun 24;54(25):9835-9849. doi: 10.1039/d5dt00633c.

Molecular Alterations in Core Subunits of Mitochondrial Complex I and Their Relation to Parkinson's Disease

Epifane-de-Assunção MC, Bispo AG, Ribeiro-Dos-Santos Â, Cavalcante GC.

Mol Neurobiol. 2025 Jun;62(6):6968-6982. doi: 10.1007/s12035-024-04526-5. Epub 2024 Sep 27.

Copper in human health: From COVID 19 to neurodegenerative diseases

Deloncle R, Guillard O, Pineau A.

J Trace Elem Med Biol. 2025 Jun;89:127636. doi: 10.1016/j.jtemb.2025.127636. Epub 2025 Mar 28.

A bibliometric analysis of acupuncture treatment and cognitive impairment

Yu X, Lu F, Chen J, Liu X, Chen Q.

Front Neurol. 2025 Jun 6;16:1495191. doi: 10.3389/fneur.2025.1495191. eCollection 2025.

miRNAs in neurodegenerative diseases: from target screening to precision therapy

Liao D, Zhang Y, Li S, Tang H, Bai X.

Neurol Sci. 2025 Jun;46(6):2393-2399. doi: 10.1007/s10072-025-08051-8. Epub 2025 Feb 19.

The neuroprotective effects of cholecystokinin in the brain: antioxidant, anti-inflammatory, cognition, and synaptic plasticity

Cui H, Li Z, Sun H, Zhao W, Ma H, Hao L, Zhang Z, Hölscher C, Ma D, Zhang Z.

Rev Neurosci. 2025 Jan 21;36(4):339-350. doi: 10.1515/revneuro-2024-0142. Print 2025 Jun 26.

Use of Smartphones and Wrist-Worn Devices for Motor Symptoms in Parkinson's Disease: A Systematic Review of Commercially Available Technologies

Triolo G, Ivaldi D, Lombardo R, Quartarone A, Lo Buono V.

Sensors (Basel). 2025 Jun 14;25(12):3732. doi: 10.3390/s25123732.

Metabolic effects of deep brain stimulation in Parkinson's disease - a systematic review and meta-analysis

Węgrzynek-Gallina J, Chmiela T, Kasprzyk A, Borończyk M, Siuda J.

Neurol Neurochir Pol. 2025 Jun 11. doi: 10.5603/pjnns.100297. Online ahead of print.

γ neuromodulations: unraveling biomarkers for neurological and psychiatric disorders

Dai ZP, Wen Q, Wu P, Zhang YN, Fang CL, Dai MY, Zhou HL, Wang H, Tang H, Zhang SQ, Li XK, Ji JS, Chu LX, Wang ZG.

Mil Med Res. 2025 Jun 27;12(1):32. doi: 10.1186/s40779-025-00619-x.

Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System

Sikiric P, Seiwerth S, Skrtic A, Staresinic M, Strbe S, Vuksic A, Sikiric S, Bekic D, Soldo D, Grizelj B, Novosel L, Beketic Oreskovic L, Oreskovic I, Stupnisek M, Boban Blagaic A, Dobric I.

Pharmaceuticals (Basel). 2025 Jun 19;18(6):928. doi: 10.3390/ph18060928.

Driving Therapeutic Innovation in Neurodegenerative Disease with Hydrogen Deuterium eXchange Mass Spectrometry

Pierangelini A, Kessler BM, O'Brien DP.

Mol Cell Proteomics. 2025 Jun 20:101017. doi: 10.1016/j.mcpro.2025.101017. Online ahead of print.

Combining immersive exergaming with physiotherapy in a specialized intensive Parkinson's disease rehabilitation program: a randomized controlled trial

Pimenta Silva D, Bouça-Machado R, Pona-Ferreira F, Lobo T, Cacho R, Anker R, Krakauer JW, Ferreira JJ.

J Neuroeng Rehabil. 2025 Jun 11;22(1):131. doi: 10.1186/s12984-025-01640-w.

Reply: "Enhancing Parkinson's Disease Research: Recommendations for Addressing Genetic and Environmental Influences in Family History Studies"

Arienti F, Monfrini E, Di Fonzo A.

Mov Disord Clin Pract. 2025 Jun;12(6):887-888. doi: 10.1002/mdc3.70034. Epub 2025 Apr 2.